UT Microbe Hackers Competitors

Novozymes has combined with Chr. Hansen to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet. Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and Novo A/S. Novozymes was the world leader in biological solutions with a commitment to Rethink Tomorrow. It served 130 markets with enzymatic, microbial and advanced protein solutions. The company’s solutions enabled higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits. In December 2022, Novozymes and Chr. Hansen entered into an agreement to create a leading global biosolutions partner by combining the two companies. The goal was to unleash the full potential of biosolutions and generate significant value for all stakeholders and society. The combination was completed on January 29, 2024 and Novonesis was born. The name means ‘a new beginning’ and is derived from the Greek word ‘genesis’. It reflects a new era where we’ll better our world with biology. You can find Novonesis on LinkedIn here: linkedin.com/company/novonesis. Novozymes A/S, part of Novonesis Group.

Pivot Bio is one of the world's leading innovative agtech companies, delivering farmers patented crop nutrition technologies.

We are accelerating the world's transformation to sustainable materials, by replacing fossil fuel sources with plants. We believe that all products should be responsibly sourced, traceable, and transparent — the sustainable source™. At Geno, we are breaking the planet's reliance on these fossil fuels by creating something better. Our vision to drive climate action at scale starts by making the same molecules, ingredients, and materials we rely on every day, but deriving them from more sustainable sources. Spanning products across a wide variety of industries, Geno’s technologies power high-performance at leading scale and volume, delivering plant-derived ingredients to some of the world’s largest brands. And with that we are shaping the creation of more transparent, traceable, and responsible global supply chains for brands and their consumers to rely on. Our technology and capabilities, developed and honed over two decades, harness the ever-increasing power of biotechnology, where microorganisms and industrial processes are designed to ferment plant sugars into materials and ingredients. Geno's Innovation Center is home to our world-class research and development team of engineers and scientists who have deployed more than $300 million in technology investment, collaborating to create a portfolio of 2,200 patents and applications. The IP covers product pathways, synthetic biology approaches to engineering microorganisms, processes to bio-manufacture products, their sometimes unique biological compositions, and product applications. We work closely with some of the world’s leading brands to develop solutions that align superior performance and economics with sustainability. We also produce and market our own branded products and license our geno technology to some of the world’s largest manufacturers including Novamont, Qore® (a joint venture of Cargill and HELM), Covestro, and Aquafil. Feeling like you’d be a fit? Join us: http://www.genomatica.com/careers/